COVID-19, caused by SARS-Cov-2, has transformed daily life across the globe in a few short months and has unleashed a scientific race to restore the economy and save patients. With the speed of COVID-19's spread and its associated social and economic impact, an effective and speedy solution is required. As a result, scientists have been unleashing AI and big data on COVID-19 to find drugs to treat it and vaccines to prevent it. AI in drug discovery has been under development for more than a decade to bring down drug development costs, which increased on average to more than $2.5 billion – a greater than 25× increase over the past 30 years.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)